The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 ...

The Canadian pharmaceutical industry is still waiting to learn about tariffs as high as 200 per cent on exports to the U.S.

Analysts anticipate Biomarin Pharmaceutical to report an earnings per share (EPS) of $0.93. The market awaits Biomarin ...

President Trump's Aug. 1 tariffs were having a ripple effect across global markets on Friday, weighing on investor sentiment and European stocks were escaping that sel ...

At long last, the Trump administration’s much-ballyhooed tariffs on pharmaceutical imports are materializing in a trade deal ...

Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for ...

We recently compiled a list of 11 Best Future Stocks to Buy Now. Ultragenyx Pharmaceutical Inc. stands first on our list.

Japan Half-Year Ended June 30 PARENT 2025 2024 Revenue Y31.38 bln Y28.31 bln Operating Profit Y3.15 bln Y3.14 bln Pretax Profit Y3.47 bln Y2.99 bln Net Profit Y2.59 bln Y2.22 bln Per share Earnings ...